Company
Cronos Group Inc
NASDAQ:CRON
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach®, PEACE NATURALS®, and Lord Jones®.
114 stories · page 1 of 6
Buds & Duds: Cannabis stocks drop as Cowen cuts Canadian pot sector outlook
The Flowr Corporation and Canntab Therapeutics both saw early gains on Monday after Health Canada approvals
Buds & Duds: Cannabis stocks stay flattish, Youngevity dips after reorganizing its board
The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, lost 0.3% to 96.8 points
Buds & Duds: Cannabis stocks lackluster heading into weekend; HEXO files financial statements
Most major cannabis stocks found themselves in the red on Friday morning
Buds & Duds: Cannabis stocks cruise flat on Thursday, but Codebase Ventures jumps as it explores CBD opportunities in Europe
Also on the move Thursday were Empower Clinics, Cronos and Aphria
Archive
NA Proactive news snapshot: CytoDyn, Namaste Technologies, Osino Resources UPDATED …
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Heritage Cannabis to supply Cronos with vaporizer devices for Canadian adult-use, medical markets
The manufacturing agreement has a two-year term with an option to extend, at an annual potential contract value of C$35 million
Buds & Duds: Cannabis stocks trip and stumble, HEXO sinks on 3Q earnings
Also on the move were MariMed, Cronos, Namaste, Terra Tech and High Hampton
Buds & Duds: Cannabis stocks slip but Valens shares jump on expanded extraction deal with Tilray
Also on the move were Origin House, Cresco, High Hampton, Cronos, Planet 13 and Emerald Health
Buds & Duds: Cannabis stocks start the week with gusto, as Tilray shares soar
Also on the move were Harvest One, Cronos, Cresco and Green Growth Brands
Buds & Duds: Cannabis stocks cruise flat; Cronos shares soar on coveted double upgrade
Also on the move were True Leaf, MedMen, TILT and Tilray
Investments and investor services
Cronos Group shares pop on rare double upgrade Bank of America Merrill Lynch analyst
Christopher Carey upgraded the cannabis company to Buy from Underperform and boosted his price target to $20 from $13
Buds & Duds: Cannabis stocks climb; Canntab shares soar on hemp-cultivation licence
Also on the move were PreveCeutical, The Supreme Cannabis Company, Cronos, Golden Leaf Holdings and Isodiol International
Cronos inks cannabis concentrate supply agreement with MediPharm Labs
The cannabis companies also agreed to a tolling deal in which Cronos will pay MediPharm to process its cannabis into resin
Buds & Duds: Cannabis stocks sink; Newstrike and Hexo shares tumble even as acquisition moves forward
Also on the move were Cronos, Aurora, TILT and Vivo
Buds & Duds: Cannabis stocks close up on Friday after flat start; Next Green Wave shares surge
Also on the move were Valens, Cronos, TerraTech and Aurora
Cronos shares sink as it reports wider loss and revenue miss in 1Q
Cronos shares sank on Thursday after the cannabis producer announced its earnings results showing the producer widened its loss and missed on revenue in 1Q